COMPARE · Data as of August 28, 2026
HOOD vs NMR
Verdict: Side-by-side breakdown using the Bull Rankings model. HOOD scored 77.0, NMR scored 69.0 — HOOD leads.
Compare another set
HOOD
Robinhood Markets, Inc.
53.2Fin
$109.76 · $98.7B
fundamentals as of
Strength gap
13.9
NMR leads
NMR
Nomura Holdings, Inc.
67.1Fin
$10.30 · $30.1B
At a glance · who leads each dimension, on the model's own rules
- CheapestNMR12.1x
- Fastest growthHOOD+51.6%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
Fundamentals, head-to-head
HOOD
NMR
+51.6%A
Rev
+10.8%B
48.1xD
P/E
12.1xB+
23.6%A-
ROE
11.2%B
10.41D
P/B
1.25B+
0.0%C
Yield
3.2%B
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
The companies
HOODRobinhood Markets, Inc.
Why now
Capital Markets · market cap $98.7b. Down 29% from 52-week high of $153.86 — deep drawdown territory. Revenue growing +52% — in hypergrowth territory. 26 sell-side analysts rate this a Buy with a mean 1-yr target of $120.08 (implying +9% upside).
Moat
Net margin 42% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 24% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. $98.7b market cap gives the company enough scale to absorb fixed costs that subscale competitors can't, without yet being so large that growth has to come from acquisition.
Risk
D/E 2.40 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Beta 2.32 implies above-market volatility — position-size to the drawdowns this name will produce in a market correction, not to its bull-case return. Trailing P/E 48x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
NMRNomura Holdings, Inc.
Why now
Capital Markets · market cap $30.1b. Trading near 52-week high of $10.36 — momentum setup, limited technical margin of safety. Revenue growing +11%, comfortably above the S&P median. PEG 0.81 — paying under fair value for the growth rate.
Moat
Net margin 17% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 11% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. Financial moat — scale of deposit base / underwriting franchise plus regulatory capital advantages. The largest players compound book value through cycles that erase smaller competitors.
Risk
D/E 9.46 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Trading within 1% of the 52-week high — limited technical margin of safety; a momentum reversal would test conviction. Balance-sheet financial — book value, net interest margin, and credit loss provisions are the lever points; a rates regime change or a deterioration in the loan book moves the stock more than EPS does.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.